跳至主要内容
临床试验/NCT05790590
NCT05790590招募中不适用

Comparison of Image Quality Between "Double Low Dose" Liver CT Using AI-based Iodine Boosting Reconstruction and Standard Contrast-enhanced Liver CT in Patients With Colorectal Cancer: Prospective, Randomized, Non-inferiority Trial

Seoul National University Hospital2 个研究点 分布在 1 个国家目标入组 176 人开始时间: 2023年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
176
试验地点
2
主要终点
lesion conspicuity on portal venous phase

研究概览

简要总结

In patients with malignancies, contrast-enhanced abdominal CT (hereafter abdominal CT) plays an important role in detecting carcinoma recurrence and assessing treatment response. In this study, we aim to investigate whether such a "double low" dose CT is feasible in patients with liver metastases of colorectal cancer using a vendor-agnostic artificial intelligence-based noise reduction and contrast enhancement software.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • colorectal cancer (CRC) patients
  • on surveillance or monitoring for liver metastasis (of CRC)

排除标准

  • any relative or absolute contra-indication of CECT
  • diffuse infiltrative type of liver metastasis or on monitoring for too many liver lesions

结局指标

主要结局

lesion conspicuity on portal venous phase

时间窗: 6 months after primary study completion.

qualitative analysis of lesion conspicuity on portal venous phase on five-point scale (higher score indicates better conspicuity). Lesion conspicuity is compared between the two arms.

次要结局

  • Radiation dose(1 month after primary study completion)
  • lesion conspicuity on arterial phase(6 months after primary study completion.)
  • Contrast media (CM) dose(1 month after primary study completion)
  • lesion detectability(12 months after primary study completion.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Min Lee

Professor

Seoul National University Hospital

研究点 (2)

Loading locations...

相似试验